Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets to form a U.S.-based 'Newco,' explain experts at Orrick.
Middlesex County, NJ, is a hotbed for the life sciences, offering a deep talent pool, an extensive R&D presence, and dedicated backing by local government in the form of strategic investment.
This insightful roundtable discussion delves into the findings from Greenphire’s 2024 Market Trends Survey. Experts uncover the key challenges and priorities shaping clinical trials in 2025.
The FDA's regulatory endorsement of DCTs enhances their credibility, offering a pathway to more inclusive and accessible clinical research that benefits both patients and sponsors.
Nanoform CEO Edward Haeggstrom and Shawn Davies, head of drug delivery, biopharmaceuticals development, AstraZeneca, discuss the potential of nanoscale medicines and delivery devices.
Explore the dedication of a father who lost his daughter to DIPG as he advocates advancing pediatric brain tumor research and systemic change in clinical trial accessibility.
From predictive AI to the European Health Data Space, learn how digital transformation is reshaping patient care and creating new pathways for commercial success in pharmaceuticals.
Review the different technologies that are being used to develop next-generation vaccines and the challenges and opportunities that these technologies present.
